Development and validation of a lung cancer risk prediction model in Ethiopia

An advanced stage of presentation is common among lung cancer patients in low-resource settings, leading to late diagnosis and poor prognosis. Early identification of high-risk individuals is essential to enable targeted prevention and timely diagnosis. We conducted a case–control study including 1,255 adults (251 lung cancer cases and 1,004 controls) to develop a lung cancer risk prediction model. A multivariable logistic regression model was fitted, and 10-fold cross-validation and 2,000 bootstrap resamples were performed to check internal validation. A simplified point-based risk score was derived to enhance practical applicability. The final model included age, sex, household solid fuel use, asbestos exposure, years of smoking, years of exposure to secondhand smoke, prior tuberculosis, and family history of cancer as predictors. The model demonstrated good discrimination (AUC = 0.775), with consistent performance across bootstrap resampling and cross-validation. At the optimal cutoff, the model achieved 72% sensitivity and 72% specificity. The simplified risk score showed comparable discriminatory performance and classification accuracy. This study presents a locally relevant lung cancer risk prediction model and a simplified risk score based on readily obtainable predictors. These tools may support the identification of high-risk individuals in resource-limited settings and inform targeted screening and prevention strategies. However, external validation is required to establish the model’s generalizability. Recalibration to population-level incidence would be required if the model is used to estimate absolute risk or define population-based clinical or public health thresholds.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-09-18
DOI
https://doi.org/10.1186/s12885-026-16997-x
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Development and validation of a lung cancer risk prediction model in Ethiopia

Gudina Egata, Hanan Yusuf, Nathan Estifanos, Negussie Deyessa et al.
BMC Cancer
Global Cancer Incidence and Screening
article

Development and validation of a lung cancer risk prediction model in Ethiopia

Gudina Egata, Hanan Yusuf, Nathan Estifanos, Negussie Deyessa, Adamu Addissie, Amsalu Bitew, Amanueal Getachew
article en

Abstract

An advanced stage of presentation is common among lung cancer patients in low-resource settings, leading to late diagnosis and poor prognosis. Early identification of high-risk individuals is essential to enable targeted prevention and timely diagnosis. We conducted a case–control study including 1,255 adults (251 lung cancer cases and 1,004 controls) to develop a lung cancer risk prediction model. A multivariable logistic regression model was fitted, and 10-fold cross-validation and 2,000 bootstrap resamples were performed to check internal validation. A simplified point-based risk score was derived to enhance practical applicability. The final model included age, sex, household solid fuel use, asbestos exposure, years of smoking, years of exposure to secondhand smoke, prior tuberculosis, and family history of cancer as predictors. The model demonstrated good discrimination (AUC = 0.775), with consistent performance across bootstrap resampling and cross-validation. At the optimal cutoff, the model achieved 72% sensitivity and 72% specificity. The simplified risk score showed comparable discriminatory performance and classification accuracy. This study presents a locally relevant lung cancer risk prediction model and a simplified risk score based on readily obtainable predictors. These tools may support the identification of high-risk individuals in resource-limited settings and inform targeted screening and prevention strategies. However, external validation is required to establish the model’s generalizability. Recalibration to population-level incidence would be required if the model is used to estimate absolute risk or define population-based clinical or public health thresholds.

BMC Cancer
Wollo University (ET), African Society for Laboratory Medicine (ET), Addis Ababa University (ET)
Bristol-Myers Squibb Foundation
Reduced inequalities
Openalex Percentile: Top 14%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.